VIRT Stock Analysis: Virtu Financial | NYSE
Capital Markets | NYSE, USA | Market Cap: 13.292m USD | 12M Return: 44.3% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 75.9M
EPS Trend: 96.1%
Qual. Beats: 4
Rev. Trend: 98.5%
Qual. Beats: 11
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Virtu Financial, Inc. is a New York-headquartered financial services company founded in 2008 and listed on the NYSE since April 2015. It operates in the United States, Ireland, and internationally across two reporting segments: Market Making and Execution Services.
In its Market Making segment, the company buys and sells securities with broker-dealers, banks, and institutions, and routes orders to exchanges, alternative trading systems (ATS), and other market centers. This is the classic liquidity-providing model used by electronic market makers, who earn revenue primarily from the spread between bid and ask prices rather than taking large directional risk.
The Execution Services segment offers agency-based, execution-only trading, workflow technology, trading analytics, and pre- and post-trade services including data products and compliance tools. Coverage spans global equities, ETFs, fixed income, currencies, commodities, foreign exchange, futures, and cryptocurrencies, serving institutional, banking, and broker-dealer clients.
Within the GICS Financials sector and Investment Banking & Brokerage sub-industry, Virtu sits alongside other capital-markets intermediaries whose revenues are tied to trading volumes, volatility, and market activity rather than to balance-sheet lending.
- Market making revenue expands on elevated volatility and trading volumes
- Execution Services growth driven by ETF and fixed income adoption
- Aggressive capital returns continue with dividends and share buybacks
| Net Income: 551.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -3.68 > 1.0 |
| NWC/Revenue: -28.25% < 20% (prev 39.03%; Δ -67.28% < -1%) |
| CFO/TA 0.02 > 3% & CFO 503.3m > Net Income 551.0m |
| Net Debt (11.4b) to EBITDA (1.86b): 6.11 < 3 |
| Current Ratio: 0.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (86.1m) vs 12m ago 0.05% < -2% |
| Gross Margin: 59.83% > 18% (prev 60.62%; Δ -0.79% > 0.5%) |
| Asset Turnover: 18.23% > 50% (prev 17.51%; Δ 0.73% > 0%) |
| Interest Coverage Ratio: 3.71 > 6 (EBIT TTM 1.75b / Interest Expense TTM 472.0m) |
| A: -0.04 (Total Current Assets 1.27b - Total Current Liabilities 2.37b) / Total Assets 25.1b |
| B: 0.06 (Retained Earnings 1.62b / Total Assets 25.1b) |
| C: 0.08 (EBIT TTM 1.75b / Avg Total Assets 21.3b) |
| D: 0.08 (Book Value of Equity 1.73b / Total Liabilities 22.9b) |
| Altman-Z'' = 0.56 = B |
| DSRI: 0.11 (Receivables 297.6m/2.05b, Revenue 3.89b/3.07b) |
| GMI: 1.01 (GM 60.62% / 59.83%) |
| AQI: 1.14 (AQ_t 0.94 / AQ_t-1 0.82) |
| SGI: 1.27 (Revenue 3.89b / 3.07b) |
| TATA: 0.00 (NI 551.0m - CFO 503.3m) / TA 25.1b) |
| Beneish M = -3.47 (Cap -4..+1) = AA |
As of July 08, 2026, the stock is trading at USD 63.23 with a total of 1,093,291 shares traded. Over the past week, the price has changed by +8.74%, over one month by +19.26%, over three months by +33.31% and over the past year by +44.29%.
Current recommended Stop Loss: 59.70 (which is 5.6% or 1.4 ATR below the current price).
Virtu Financial has received a consensus analysts rating of 3.33. Therefore, it is recommended to hold VIRT.
- StrongBuy: 2
- Buy: 1
- Hold: 5
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 54.1 | -14.4% |
P/E Trailing = 10.2268
P/E Forward = 9.8135
P/S = 4.3583
P/B = 3.0963
P/EG = -9.42
Revenue TTM = 3.89b USD
EBIT TTM = 1.75b USD
EBITDA TTM = 1.86b USD
Long Term Debt = 9.75b USD (from longTermDebt, last quarter)
Short Term Debt = 2.37b USD (from shortTermDebt, last quarter)
Debt = 12.4b USD (corrected: LT Debt 9.75b + ST Debt 2.37b) + Leases 247.5m
Net Debt = 11.4b USD (calculated: Debt 12.4b - CCE 973.2m)
Enterprise Value = 24.7b USD (13.3b + Debt 12.4b - CCE 973.2m)
Interest Coverage Ratio = 3.71 (Ebit TTM 1.75b / Interest Expense TTM 472.0m)
EV/FCF = 56.40x (Enterprise Value 24.7b / FCF TTM 437.8m)
FCF Yield = 1.77% (FCF TTM 437.8m / Enterprise Value 24.7b)
FCF Margin = 11.26% (FCF TTM 437.8m / Revenue TTM 3.89b)
Net Margin = 14.17% (Net Income TTM 551.0m / Revenue TTM 3.89b)
Gross Margin = 59.83% ((Revenue TTM 3.89b - Cost of Revenue TTM 1.56b) / Revenue TTM)
Gross Margin QoQ = 62.40% (prev 50.88%)
Tobins Q-Ratio = 0.98 (Enterprise Value 24.7b / Total Assets 25.1b)
Interest Expense / Debt = 3.82% (Interest Expense 472.0m / Debt 12.4b)
Taxrate = 16.48% (210.9m / 1.28b)
NOPAT = 1.46b (EBIT 1.75b * (1 - 16.48%))
Current Ratio = 0.54 (Total Current Assets 1.27b / Total Current Liabilities 2.37b)
Debt / Equity = 7.13 (Debt 12.4b / totalStockholderEquity, last quarter 1.73b)
Debt / EBITDA = 6.11 (Net Debt 11.4b / EBITDA 1.86b)
Debt / FCF = 26.04 (Net Debt 11.4b / FCF TTM 437.8m)
Total Stockholder Equity = 1.54b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.58% (Net Income 551.0m / Total Assets 25.1b)
RoE = 35.67% (Net Income TTM 551.0m / Total Stockholder Equity 1.54b)
RoCE = 15.51% (EBIT 1.75b / Capital Employed (Equity 1.54b + L.T.Debt 9.75b))
RoIC = 5.87% (NOPAT 1.46b / Invested Capital 24.9b)
WACC = 5.09% (E(13.3b)/V(25.7b) * Re(6.87%) + D(12.4b)/V(25.7b) * Rd(3.82%) * (1-Tc(0.16)))
Discount Rate = 6.87% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -82.22 | Cagr: -3.88%
[DCF] Terminal Value 73.10% ; FCFF base≈643.3m ; Y1≈564.1m ; Y5≈455.8m
[DCF] Fair Price = N/A (negative equity: EV 7.32b - Net Debt 11.4b = -4.08b; debt exceeds intrinsic value)
EPS Correlation: 96.14 | EPS CAGR: 66.32% | SUE: 3.71 | # QB: 4
Revenue Correlation: 98.48 | Revenue CAGR: 25.42% | SUE: 0.94 | # QB: 11
EPS current Quarter (2026-06-30): EPS=1.50 | Chg30d=+0.96% | Revisions=+44% | Analysts=7
EPS next Quarter (2026-09-30): EPS=1.34 | Chg30d=+2.29% | Revisions=+38% | Analysts=7
EPS current Year (2026-12-31): EPS=6.49 | Chg30d=+0.99% | Revisions=+67% | GrowthEPS=+13.3% | GrowthRev=+15.2%
EPS next Year (2027-12-31): EPS=5.95 | Chg30d=+1.61% | Revisions=+70% | GrowthEPS=-8.3% | GrowthRev=-6.7%
[Analyst] Revisions Ratio: +74% (up=22, down=2)